Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 42.16
+0.56 (1.35%)
Sep 3, 2025, 4:08 PM HKT
HKG:2591 Statistics
Total Valuation
HKG:2591 has a market cap or net worth of HKD 19.26 billion. The enterprise value is 18.52 billion.
| Market Cap | 19.26B |
| Enterprise Value | 18.52B |
Important Dates
The last earnings date was Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2591 has 456.82 million shares outstanding.
| Current Share Class | 420.29M |
| Shares Outstanding | 456.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.12% |
| Owned by Institutions (%) | 45.91% |
| Float | 234.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 311.38 |
| PB Ratio | 25.74 |
| P/TBV Ratio | 26.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -76.16 |
| EV / Sales | 299.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.55 |
| Quick Ratio | 3.36 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -552.12 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -33.66% |
| Revenue Per Employee | 589,071 |
| Profits Per Employee | -2.32M |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 2,014,098 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2591 had revenue of HKD 61.85 million and -243.14 million in losses. Loss per share was -0.58.
| Revenue | 61.85M |
| Gross Profit | 55.33M |
| Operating Income | -257.13M |
| Pretax Income | -243.14M |
| Net Income | -243.14M |
| EBITDA | -241.03M |
| EBIT | -257.13M |
| Loss Per Share | -0.58 |
Balance Sheet
The company has 804.28 million in cash and 62.36 million in debt, giving a net cash position of 741.92 million or 1.62 per share.
| Cash & Cash Equivalents | 804.28M |
| Total Debt | 62.36M |
| Net Cash | 741.92M |
| Net Cash Per Share | 1.62 |
| Equity (Book Value) | 748.11M |
| Book Value Per Share | 1.78 |
| Working Capital | 674.31M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 89.45% |
| Operating Margin | -415.71% |
| Pretax Margin | -393.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:2591 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -1.26% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |